News-Medical.Net on MSN
Study finds GLP-1 drugs improve strength and reverse aging biology in mice
Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight.
Allied Market Research published a report, titled, "Bone Health Supplements Market by Type (Vitamins, Calcium, Collagen, Omega-3, Glucosamine, and Others), Dosage Form (Tablets, Capsules, Powder, and ...
Katelyn Peters has a writer and editor for more than five years who focuses on both investing and personal finance content. In addition to her experience in finance, she is also a volunteer editorial ...
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® (pertuzumab-dpzb) ...
WEX Inc. (WEX) 7th Annual Healthcare Symposium November 14, 2025 9:50 AM ESTCompany ParticipantsChris ByrdConference Call ParticipantsDaniel ...
Everyday Health on MSN
8 of Today’s Best Smartwatches for Everything from Timing to Tracking
A round-up of the best smartwatches for anyone looking to stay on time while tracking their health, fitness, sleep habits, ...
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...
DelveInsight's Mitochondrial Myopathies Market Insights report includes a comprehensive understanding of current treatment practices, mitochondrial myopathies emerging drugs, market share of ...
This Class 5 GK Quiz, designed by Times Now Digital brings together 25 multiple-choice questions covering Science, History ...
A study unveils a novel strategy to combat Alzheimer’s disease (AD) by targeting muscle health. Researchers found that ...
Download the AP TET Syllabus for Paper I and Paper II in PDF format on this page. Also get to know the AP TET exam pattern ...
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced the appointment of biotechnology veteran Christopher Martin to its Board of Directors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results